ENTRY       D10755            Mixture   Drug
NAME        Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide;
            Genvoya (TN)
PRODUCT     GENVOYA (Gilead Sciences)
COMPONENT   Elvitegravir [DR:D06677], Cobicistat [DR:D09881], Emtricitabine [DR:D01199], (Tenofovir alafenamide fumarate [DR:D10605] | Tenofovir alafenamide [DR:D10428])
CLASS       Antiviral
             DG03107  Anti-HIV agent
REMARK      Therapeutic category: 6250
            ATC code: J05AR18
            Product: D10755<JP/US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
            HIV-1 integrase [KO:K24803]
  PATHWAY   ko03230(K24802+K24803)  Viral genome structure
            ko03240(K24802+K24803)  Viral replication
            ko03250(K24802+K24803)  Viral life cycle - HIV-1
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR18 Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
                  D10755  Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Alafenamide Fumarate
                D10755  Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D10755  Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               D10755  Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D10755  Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV integrase inhibitor
                D10755  Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10755
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10755
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10755
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10755
DBLINKS     PubChem: 273220351
            ChEBI: 90922
///
